Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	5 Months Ended	7 Months Ended	12 Months Ended
	Dec. 31, 2015	Aug. 14, 2015	Dec. 31, 2014	Dec. 31, 2013
Cash flow from operating activities:
Net income (loss)		$ (120,649)
Predecessor [Member]
Cash flow from operating activities:
Net income (loss)		(120,649)	$ (285,376)	$ (27,259)
Adjustments to reconcile net loss to cash provided by operations:
Depreciation and amortization		45,461	119,708	123,397
Impairment of long-lived assets and goodwill		35,381	197,220	0
Rationalization related fixed asset write offs		0	926	8,010
Inventory write-downs		0	19,600	0
Deferred income taxes		924	(16,003)	(22,369)
Post-retirement and pension plan changes		2,998	23,047	(10,544)
Stock-based compensation		15,357	5,577	8,035
Non-cash interest expense		14,180	15,693	14,052
Other charges, net		102	1,441	7,162
Decrease in working capital		45,594	56,846	31,980
Increase in long-term assets and liabilities		(11,025)	(17,776)	(15,627)
Net cash provided by operating activities		28,323	120,903	116,837
Cash flow from investing activities:
Capital expenditures		(32,301)	(84,981)	(86,344)
Insurance recoveries			2,834	1,500
Derivative instrument settlements, net		(8,263)	(2,025)	114
Proceeds from the sale of fixed assets		646	5,042	0
Other		0	178	929
Net cash used in investing activities		(39,918)	(78,952)	(83,801)
Cash flow from financing activities:
Short-term debt (reductions) borrowings, net		18,511	(1,021)	(7,265)
Revolving Facility borrowings		160,000	269,000	166,000
Revolving Facility reductions		(99,000)	(293,000)	(171,500)
Repayment of Senior Subordinated Notes		(200,000)	0	0
Issuance of preferred shares		150,000	0	0
Principal payments on long-term debt		(89)	(192)	(225)
Supply chain financing		0	(9,455)	(17,508)
Proceeds from exercise of stock options		32	2,813	448
Purchase of treasury shares		(63)	(894)	(1,825)
Refinancing fees and debt issuance costs		(5,068)	(3,279)	(560)
Other		(3,499)	951	(5,210)
Net cash (used in) provided by financing activities		20,824	(35,077)	(37,645)
Net (decrease) increase in cash and cash equivalents		9,229	6,874	(4,609)
Effect of exchange rate changes on cash and cash equivalents		(1,746)	(1,212)	(820)
Cash and cash equivalents at beginning of period	$ 25,033	17,550	11,888	17,317
Cash and cash equivalents at end of period		25,033	17,550	11,888
Supplemental disclosures of cash flow information:
Interest		10,661	21,549	21,825
Income taxes		5,016	10,611	8,357
Non-cash operating, investing and financing activities:
Common stock issued to savings and pension plan trusts		1,874	4,381	4,561
Decrease (increase) in current assets:
Accounts and notes receivable, net		61,008	28,466	37,366
Inventories		1,164	77,875	14,324
Prepaid expenses and other current assets		2,551	(14,898)	(209)
Decrease in accounts payables and accruals		(18,728)	(25,849)	(38,198)
Rationalizations		(2,677)	(8,732)	18,421
Increase in interest payable		2,276	(16)	276
Decrease in working capital		45,594	$ 56,846	$ 31,980
Successor [Member]
Cash flow from operating activities:
Net income (loss)	(33,551)
Adjustments to reconcile net loss to cash provided by operations:
Depreciation and amortization	28,618
Impairment of long-lived assets and goodwill	0
Rationalization related fixed asset write offs	0
Inventory write-downs	0
Deferred income taxes	5,368
Post-retirement and pension plan changes	2,638
Stock-based compensation	0
Non-cash interest expense	2,351
Other charges, net	(1,934)
Decrease in working capital	26,763
Increase in long-term assets and liabilities	(7,138)
Net cash provided by operating activities	23,115
Cash flow from investing activities:
Capital expenditures	(18,442)
Insurance recoveries	0
Derivative instrument settlements, net	326
Proceeds from the sale of fixed assets	632
Other	0
Net cash used in investing activities	(17,484)
Cash flow from financing activities:
Short-term debt (reductions) borrowings, net	(15,504)
Revolving Facility borrowings	62,000
Revolving Facility reductions	(68,000)
Repayment of Senior Subordinated Notes	0
Issuance of preferred shares	(1,385)
Principal payments on long-term debt	(183)
Supply chain financing	0
Proceeds from exercise of stock options	0
Purchase of treasury shares	0
Refinancing fees and debt issuance costs	0
Other	(1,385)
Net cash (used in) provided by financing activities	(23,072)
Net (decrease) increase in cash and cash equivalents	(17,441)
Effect of exchange rate changes on cash and cash equivalents	(665)
Cash and cash equivalents at beginning of period	25,033
Cash and cash equivalents at end of period	6,927	$ 25,033
Supplemental disclosures of cash flow information:
Interest	10,880
Income taxes	1,646
Non-cash operating, investing and financing activities:
Common stock issued to savings and pension plan trusts	0
Decrease (increase) in current assets:
Accounts and notes receivable, net	(9,524)
Inventories	47,853
Prepaid expenses and other current assets	15,935
Decrease in accounts payables and accruals	(21,503)
Rationalizations	(3,756)
Increase in interest payable	(2,242)
Decrease in working capital	$ 26,763